Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Tsvetelin Lukanov, Milena Ivanova, Petya Yankova, Bushra Al Hadra, Anastasiya Mihaylova, Marianka Genova, Dobrin Svinarov & Elisaveta Naumova. (2022) Impact of CYP3A7, CYP2D6 and ABCC2/ABCC3 polymorphisms on tacrolimus steady state concentrations in Bulgarian kidney transplant recipients. Biotechnology & Biotechnological Equipment 36:1, pages 362-369.
Read now
Read now
Chi Chiu Mok. (2017) Therapeutic monitoring of the immuno-modulating drugs in systemic lupus erythematosus. Expert Review of Clinical Immunology 13:1, pages 35-41.
Read now
Read now
Mona Fathy, Manal Kamal, Abeer Mohy & Ahmad Nabil. (2016) Impact of CYP3A5 and MDR-1 gene polymorphisms on the dose and level of tacrolimus among living-donor liver transplanted patients: single center experience. Biomarkers 21:4, pages 335-341.
Read now
Read now
Karolína Hronová, Martin Šíma, Svatopluk Světlík, Olga Matoušková & Ondřej Slanař. (2014) Pharmacogenetics and immunosuppressive drugs. Expert Review of Clinical Pharmacology 7:6, pages 821-835.
Read now
Read now
Articles from other publishers (28)
Fahadul Islam, Md. Rezaul Islam, Mohamed H. Nafady, Md. Faysal, Sharuk L. Khan, Mehrukh Zehravi, Talha Bin Emran & Md. Habibur Rahman. 2023. Pharmacogenomics. Pharmacogenomics
323
344
.
S. Djabarouti, P. Mora, M. Lahouati, M. Gigan, N. d’Houdain, B. Sourisseau, J. Chambord & F. Xuereb. (2022) Intérêt des dosages pharmacologiques d’immunosuppresseurs et immunomodulateurs dans la prise en charge des maladies autoimmunes. La Revue de Médecine Interne 43:7, pages 412-418.
Crossref
Crossref
Fang Cheng, Qiang Li, Jinglin Wang, Fang Zeng & Yu Zhang. (2021) Effects and safety evaluation of Wuzhi Capsules combined with tacrolimus for the treatment of kidney transplantation recipients. Journal of Clinical Pharmacy and Therapeutics 46:6, pages 1636-1649.
Crossref
Crossref
Daniel A. Brazeau, Kristopher Attwood, Calvin J. Meaney, Gregory E. Wilding, Joseph D. Consiglio, Shirley S. Chang, Aijaz Gundroo, Rocco C. Venuto, Louise Cooper & Kathleen M. Tornatore. (2020) Beyond Single Nucleotide Polymorphisms: CYP3A5∗3∗6∗7 Composite and ABCB1 Haplotype Associations to Tacrolimus Pharmacokinetics in Black and White Renal Transplant Recipients. Frontiers in Genetics 11.
Crossref
Crossref
Desmond Y H Yap, Chun Hay Tam, Susan Yung, Sunny Wong, Colin S O Tang, Temy M Y Mok, Catherine K Y Yuen, Maggie K M Ma, Chak Sing Lau & Tak Mao Chan. (2020) Pharmacokinetics and pharmacogenomics of mycophenolic acid and its clinical correlations in maintenance immunosuppression for lupus nephritis. Nephrology Dialysis Transplantation 35:5, pages 810-818.
Crossref
Crossref
Sahar El-Shair, Mohammad Al Shhab, Khaled Zayed, Moaath Alsmady & Malek Zihlif. (2019) Association Between CYP3A4 and CYP3A5 Genotypes and Cyclosporine's Blood Levels and Doses among Jordanian Kidney Transplanted Patients. Current Drug Metabolism 20:8, pages 682-694.
Crossref
Crossref
. Experimental and Clinical Transplantation 16:3.
Crossref
Crossref
José Pablo Werba, Shingen Misaka, Monica Gianna Giroli, Kenju Shimomura, Manuela Amato, Niccolò Simonelli, Lorenzo Vigo & Elena Tremoli. (2018) Update of green tea interactions with cardiovascular drugs and putative mechanisms. Journal of Food and Drug Analysis 26:2, pages S72-S77.
Crossref
Crossref
Jian-Hua Liao, Chang-Can Li, Shao-Han Wu, Jun-Wei Fan, Hai-Tao Gu & Zhao-Wen Wang. (2017) Gene Variations of Sixth Complement Component Affecting Tacrolimus Metabolism in Patients with Liver Transplantation for Hepatocellular Carcinoma. Chinese Medical Journal 130:14, pages 1670-1676.
Crossref
Crossref
Erika Y. Tamashiro, Claudia R. Felipe, Fabiana D.V. Genvigir, Alice C. Rodrigues, Antony B. Campos, Rosario D.C. Hirata, Helio Tedesco-SilvaJrJr & Jose O. Medina-Pestana. (2017)
Influence of
CYP3A4
and
CYP3A5
polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients
. Drug Metabolism and Personalized Therapy 32:2, pages 89-95.
Crossref
Crossref
Emily Brooks, Susan E. Tett, Nicole M. Isbel & Christine E. Staatz. (2016) Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?. Clinical Pharmacokinetics 55:11, pages 1295-1335.
Crossref
Crossref
Dominique Barbolosi, Joseph Ciccolini, Bruno Lacarelle, Fabrice Barlési & Nicolas André. (2015) Computational oncology — mathematical modelling of drug regimens for precision medicine. Nature Reviews Clinical Oncology 13:4, pages 242-254.
Crossref
Crossref
Lucie Pouché, Matthias Koitka, Jana Stojanova, Jean-Baptiste Woillard, Caroline Monchaud, Claire Villeneuve, Marie Essig, Julie Abraham, Yannick Le Meur, Jean-Phillippe Rerolle, Nassim Kamar, Lionel Rostaing, Pierre Merville, Peggy Gandia, Stephane Bouchet, Britt-Sabina Petersen, Pierre Marquet & Nicolas Picard. (2016) A candidate gene approach of the calcineurin pathway to identify variants associated with clinical outcomes in renal transplantation. Pharmacogenomics 17:4, pages 375-391.
Crossref
Crossref
Xandra García-González, Teresa Cabaleiro, María José Herrero, Howard McLeod & Luis A. López-Fernández. (2016) Clinical implementation of pharmacogenetics. Drug Metabolism and Personalized Therapy 31:1, pages 9-16.
Crossref
Crossref
Lin Yan, Yi Li, Jiang-Tao Tang, Yun-Fei An, Lan-Lan Wang & Yun-Ying Shi. (2016)
Donor
ABCB1
3435 C>T genetic polymorphisms influence early renal function in kidney transplant recipients treated with tacrolimus
. Pharmacogenomics 17:3, pages 249-257.
Crossref
Crossref
Rocco C. Venuto, Calvin J. Meaney, Shirley Chang, Nicolae Leca, Joseph D. Consiglio, Gregory E. Wilding, Daniel Brazeau, Aijaz Gundroo, Neha Nainani, Sarah E. Morse, Louise M. Cooper & Kathleen M. Tornatore. (2015) Association of Extrarenal Adverse Effects of Posttransplant Immunosuppression With Sex and ABCB1 Haplotypes. Medicine 94:37, pages e1315.
Crossref
Crossref
Antje Albring, Laura Wendt, Nino Harz, Harald Engler, Benjamin Wilde, Andreas Kribben, Monika Lindemann, Manfred Schedlowski & Oliver Witzke. (2015) Relationship between pharmacokinetics and pharmacodynamics of calcineurin inhibitors in renal transplant patients. Clinical Transplantation 29:4, pages 294-300.
Crossref
Crossref
Jiazhen Xing, Xiaoqing Zhang, Junwei Fan, Bin Shen, Tongyi Men & Jianning Wang. (2014) Association between interleukin-18 promoter variants and tacrolimus pharmacokinetics in Chinese renal transplant patients. European Journal of Clinical Pharmacology 71:2, pages 191-198.
Crossref
Crossref
Zhaowen Wang, Shaohan Wu, Dawei Chen, Feng Guo, Lin Zhong, Junwei Fan & Zhihai Peng. (2014) Influence of TLR4 rs1927907 locus polymorphisms on tacrolimus pharmacokinetics in the early stage after liver transplantation. European Journal of Clinical Pharmacology 70:8, pages 925-931.
Crossref
Crossref
Christine E. Staatz & Susan E. Tett. (2014) Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update. Archives of Toxicology 88:7, pages 1351-1389.
Crossref
Crossref
Jean-Baptiste Woillard, Nicolas Picard, Antoine Thierry, Guy Touchard & Pierre Marquet. (2014) Associations between polymorphisms in target, metabolism, or transport proteins of mycophenolate sodium and therapeutic or adverse effects in kidney transplant patients. Pharmacogenetics and Genomics 24:5, pages 256-262.
Crossref
Crossref
Laure Elens, Rachida Bouamar, Nauras Shuker, Dennis A. Hesselink, Teun van Gelder & Ron H. N. van Schaik. (2014) Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks. British Journal of Clinical Pharmacology 77:4, pages 715-728.
Crossref
Crossref
Jean-Baptiste Woillard, Nassim Kamar, Sandra Coste, Lionel Rostaing, Pierre Marquet & Nicolas Picard. (2013) Effect of CYP3A4*22, POR*28, and PPARA rs4253728 on Sirolimus In Vitro Metabolism and Trough Concentrations in Kidney Transplant Recipients. Clinical Chemistry 59:12, pages 1761-1769.
Crossref
Crossref
Mercè Brunet, Olga Millán & Jaume Martorell. (2013) Donor–recipient genetic diversity: the role of
pharmacogenomics in kidney transplantation. Pharmacogenomics 14:12, pages 1369-1372.
Crossref
Crossref
Inés Llaudó, Helena Colom, Pepita Giménez-Bonafé, Joan Torras, Anna Caldés, Maria Sarrias, Josep Mª Cruzado, Federico Oppenheimer, Jaime Sánchez-Plumed, Miguel Ángel Gentil, Henrik Ekberg, Josep Mª Grinyó & Núria Lloberas. (2013) Do drug transporter (ABCB1) SNPs and P-glycoprotein function influence cyclosporine and macrolides exposure in renal transplant patients? Results of the pharmacogenomic substudy within the symphony study. Transplant International 26:2, pages 177-186.
Crossref
Crossref
Yunying Shi, Yi Li, Jiangtao Tang, Junlong Zhang, Yuangao Zou, Bei Cai & Lanlan Wang. (2013) Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients. Gene 512:2, pages 226-231.
Crossref
Crossref
Yi Li, Xin Hu, Bei Cai, Jie Chen, Yangjuan Bai, Jiangtao Tang, Yun Liao & Lanlan Wang. (2012) Meta-analysis of the effect of MDR1 C3435 polymorphism on tacrolimus pharmacokinetics in renal transplant recipients. Transplant Immunology 27:1, pages 12-18.
Crossref
Crossref
Christine E. Staatz & Susan E. Tett. (2011) Maximum A Posteriori Bayesian Estimation of Mycophenolic Acid Area Under the Concentration-Time Curve: Is This Clinically Useful for Dosage Prediction Yet?. Clinical Pharmacokinetics 50:12, pages 759-772.
Crossref
Crossref